CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-01 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −7,500 | 104,774 | ||
| 2020-11-27 | Kalowski Lee President and CFO | Option exercise | +530 | $1.56 | $827 | 530 |
| 2020-11-27 | Kalowski Lee President and CFO | Sale | −530 | $20.00 | $11K | 0 |
| 2020-11-27 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −530 | 112,274 | ||
| 2020-11-25 | Kalowski Lee President and CFO | Option exercise | +9,781 | $1.56 | $15K | 9,781 |
| 2020-11-25 | Kalowski Lee President and CFO | Sale | −9,781 | $20.07 | $196K | 0 |
| 2020-11-25 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −9,781 | 112,804 | ||
| 2020-11-23 | Kalowski Lee President and CFO | Option exercise | +17,189 | $1.56 | $27K | 17,189 |
| 2020-11-23 | Kalowski Lee President and CFO | Sale | −16,976 | $19.82 | $336K | 213 |
| 2020-11-23 | Kalowski Lee President and CFO | Sale | −213 | $20.38 | $4K | 0 |
| 2020-11-23 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −17,189 | 122,585 | ||
| 2020-08-21 | Smethurst Dominic Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2020-07-15 | GLAXOSMITHKLINE PLC 10% owner | Sale | −3,069 | $19.40 | $60K | 1,910,609 |
| 2020-07-15 | GLAXOSMITHKLINE PLC 10% owner | Sale | −78 | $19.25 | $2K | 1,910,531 |
| 2020-07-14 | GLAXOSMITHKLINE PLC 10% owner | Sale | −1,597 | $19.27 | $31K | 1,913,678 |
| 2020-04-14 | Winter Gregory Paul Director | Option exercise | +71,450 | 163,927 | ||
| 2020-04-14 | Winter Gregory Paul Director | Option exercise · Series A Preferred Shares Warrant | −71,450 | 71,450 | ||
| 2020-02-21 | Crockett Nigel Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +44,757 | 44,757 | ||
| 2020-01-02 | Legault Pierre Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2020-01-02 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 |
Page 28 of 34 · 664 trades